The third round of metro trial runs was successfully held as part of Chennai Metro Rail Limited’s Phase 2 project, covering the downline stretch between Porur and Poonamallee Bypass stations.

Prime Minister Modi urged decisive global action against terrorism during a meeting with UK Foreign Secretary David Lammy, who condemned the Pahalgam attack and affirmed UK's support against cross ...

Ascletis Announces First Participants Dosed in U.S. Phase I Clinical Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor for the Treatment of Psoriasis By Ascletis Pharma ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that the first healthy participants have been dosed in a randomized, double-blind, placebo-controlled Phase I clinical trial in the U.S., ...

Florida residents voice opposition to potential offshore drilling plans The Bureau of Ocean Energy Management is taking public comments on a program that would open up nearly the entire U.S ...

The Consumer Product Safety Commission announced the recall of more than 1.7 million window air conditioners because they can allow mold to grow, posing a health risk.

The Phase 3 drill program is set to restart over the coming days, beginning with two drill rigs and expanding to three, with a total of approximately 17,500 metres planned. Directional drilling ...

A biphasic structural plasticity rule interacts with homeostatic synaptic scaling to maintain firing rate homeostasis in neural networks.

Armed with results from a phase 2 trial, Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor ...

In another article, we covered Everus Construction Group, Inc. (NYSE:ECG) and shared billionaire Rob Citrone’s small-cap stock picks with huge upside potential.

Equinor and OMV have not yet commented on the potential strike. Similarly, the Norwegian Shipowners' Association has not responded to inquiries regarding the negotiations, it was reported.

Jaguar Health Provides Update on Meeting with FDA Discussing Statistically Significant Results of Responder Analysis of Breast Cancer Patients in Phase 3 OnTarget Trial and Potential Approval ...